How Do We Solve a Problem like Shigellosis?

Key Objectives:

1. The hills (and valleys and plains) are alive with shigellosis: Overview of shigellosis burden
2. I have confidence [intervals that are large]: Gaps and opportunities in shigellosis surveillance
3. So long, farewell to oral antimicrobial options for children: Emerging issues in antimicrobial resistance
4. These are a few of my favorite things: Prevention and outbreak mitigation strategies

Brief Summary:
During this session, we will have a wide-ranging and interactive discussion about shigellosis epidemiology and prevention.  We will begin with an overview of the shigellosis burden in the United States, spotlighting high-risk groups such as young children and men who have sex with men, and then discuss hurdles, gaps, and possible opportunities to improve shigellosis surveillance.  Next, we will explore changes in antimicrobial resistance patterns among U.S. Shigella isolates, including azithromycin and quinolone resistance, and implications for patient management.  The bulk of the discussion will center on outbreak prevention and mitigation.  State and local health officials will be invited to share their experiences using health alerts, exclusion policies, hygiene interventions, and other tactics to prevent and control shigellosis in childcare settings and beyond.  We will discuss best practices, lessons learned, material and strategic requirements for better shigellosis prevention, and methods to address those needs.